Income StatementBalance SheetCash FlowSegments
Humana logo

Humana Cash Flow Statement

Operating, investing, and financing cash movements

Humana generated $3.8B in operating cash flow over the trailing twelve months. After $572.0M in capital expenditures, free cash flow was $3.4B. Free cash flow decreased 0.2% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$2.4BNet Cash From Investing (TTM)-$594.0MNet Cash From Financing (TTM)-$549.0MCapital Expenditures (TTM)$572.0MDepreciation And Amortization Cf (TTM)$756.0MNet Change In Cash (TTM)$272.0M
Latest FilingQ1 2026
Report Date2026-04-29
Market Cap$36.2B
P/E Ratio11.41
ROE17.45%

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquisitions, net of cash acquired$52.0M$0.0$1.0M$4.0M$76.0M$911.0M
Capital expenditures$154.0M$95.0M$114.0M$135.0M$202.0M$121.0M
Payment for (Proceeds from) Other Investing Activity$12.5M$0.0$0.0$0.0$0.0—
Proceeds from disposals of property, plant and equipment$1.8M$5.8M$5.8M$5.8M$5.8M—
Change in Securities Lending Collateral$57.0M$175.0M-$127.0M$93.0M$79.0M-$55.0M
Net cash from investing activities-$63.0M$314.0M$347.0M$980.0M$632.0M-$2.6B
Other investing activities$12.5M$0.0$0.0$0.0$0.0—
Proceeds from maturities/sales of investments$1.6B$522.0M$721.0M$3.8B$1.4B$395.0M
Proceeds from sale of property, plant and equipment$1.8M$5.8M$5.8M$5.8M$5.8M—
Purchases of investments$2.1B$827.0M$1.1B$3.3B$1.2B$2.9B

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Change in benefits payable—$1.0B-$391.0M-$971.0M-$121.0M$2.7B
Change in deferred revenue—$5.0M$9.0M-$9.0M$91.0M-$87.0M
Change in other assets-$745.0M$686.0M-$28.0M$716.0M$799.0M$1.4B
Change in other liabilities—$193.0M$817.0M$307.0M$5.0M$452.0M
Other working capital changes$32.0M$7.0M-$7.0M$27.0M-$27.0M$21.0M
Change in receivables$560.0M$1.8B$45.0M-$1.8B$586.0M$1.9B
Depreciation and amortization$226.0M$200.0M$196.0M$191.0M$186.0M$183.0M
Equity in income of investees-$37.0M-$43.0M-$19.0M-$26.0M-$14.0M-$16.0M
Net gains (losses) on investments$14.0M$2.0M$11.0M$53.0M-$116.0M-$1.0M
Net cash from operating activities—$331.0M$1.3B$971.0M—$1.3B
Net income—$1.2B$543.0M$194.0M—$1.2B
Stock-based compensation$54.0M$49.0M$61.0M$83.0M$48.0M$51.0M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net change in commercial paper-$12.0M-$4.0M-$1.0M$0.0$0.0$693.0M
Proceeds from issuance of debt$0.0$1.5B$0.0$0.0$0.0$990.0M
Repayments of debt$1.1B$0.0$771.0M$0.0$177.0M$10.0M
Dividends paid$108.0M$108.0M$106.0M$107.0M$109.0M$107.0M
Changes in rebate factor payable$123.0M-$68.0M-$55.0M$0.0$0.0$0.0
Payments For (Proceeds From) Contract Deposits$1.3B$35.0M$544.0M$585.0M$0.0-$673.0M
Proceeds from issuance of commercial paper and other short-term borrowings$0.0$0.0$0.0$0.0$0.0—
Proceeds from Issuance of Commercial Paper and Short-Term Borrowings$0.0$0.0$0.0$0.0$0.0—
Net cash from financing activities-$2.3B$1.4B-$1.8B-$603.0M-$168.0M$2.1B
Other financing activities-$369.0M-$12.0M-$50.0M-$14.0M-$5.0M-$18.0M
Payment of debt issuance costs$0.0$3.0M$2.0M$0.0$0.0$0.0
Proceeds from Commercial Paper and Secured Lines of Credit$0.0$0.0$0.0$0.0$0.0—
Repurchases of common stock$49.0M$9.0M$100.0M$0.0$42.0M$107.0M
Proceeds from borrowing on revolving credit facility$0.0$0.0$0.0$0.0$0.0—

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow—$236.0M$1.2B$836.0M—$1.1B

Supplemental

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Interest paid$168.0M$143.0M$150.0M$147.0M$188.0M$142.0M
Fair Value of Assets Acquired$75.0M$0.0$2.0M$4.0M$85.0M$966.0M
Liabilities assumed$23.0M$0.0$1.0M$0.0$9.0M$55.0M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net increase (decrease) in cash-$2.9B$2.0B-$210.0M$1.3B—$751.0M